Can ophthalmology be more sustainable? Over the last few years there have been many exciting developments in ophthalmology and, in particularly, anterior segment technologies. The important driver increasing growth in the global Ophthalmology drugs and devices market is the global increase in the prevalence rates of eye diseases. Global Ophthalmology drugs and devices market is compelled by increasing occurrence of eye ailments such as diabetic retinopathy, macular degeneration, and cataract, glaucoma, and visualization care devices. Ophthalmology devices are also used in medical procedures such as ultrasound phacoemulsification for sooner reclamation rates and better safety. An extensive choice of Ophthalmology devices and drugs are accessible in the market for the cure of eye disorders.
“Is the Future of Vision and Eye Care is Brain implants and Artificial Retina instead of Bionic Eyes.”
With the advancement of smartphones and other smart gadgets at lightning speed, it is only a matter of time before portable devices will appear on a large scale in ophthalmology as well. The tiny, well-designed and connected instruments and the accompanying apps make it possible to undertake eye examinations anywhere in the world – making patients the point of care. The increasing application of developed technology and innovation in devices of ophthalmology has provide useful and economical solutions for various eye-related disorders such as refractor disorders, vitreoretinal disorders, and cataract to the customer. Chronic eye diseases are the main reason of vision loss. The increasing prevalence of eye diseases among the aged group is likely to boost the growth in the market. North America is expected to be the largest market for ophthalmology devices followed by Europe. There is an intense competition between North America and Europe region. The presence of developed healthcare infrastructures coupled with growing geriatric population and rising incidence of chronic eye conditions are likely to boost the growth in this region. The Asia Pacific is expected to growth faster due to improvement in healthcare infrastructure, growing occurrence of eye disorders such as glaucoma, and rising awareness among patients.
